IL6ST and neoplasm: Since breast CSCs mediate tumor relapse and tGLI1+GP130 co-overexpression enriches breast CSCs, we next investigated if concurrent inhibition of tGLI1 and GP130 could be an effective novel combinatorial therapy to suppress breast CSCs.